MYGN – myriad genetics, inc. (US:NASDAQ)
Stock Stats
News
11/20
04:34 pm
mygn
Low
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina's Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2 [Yahoo! Finance]
11/20
04:30 pm
mygn
Low
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
11/20
03:11 am
mygn
Low
Myriad Genetics, Inc. (NASDAQ: MYGN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
11/19
08:20 am
mygn
Low
Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy [Yahoo! Finance]
11/19
08:00 am
mygn
Low
Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy
11/7/2024
04:05 pm
MYGN
-1.5%
BEAT
8/6/2024
04:05 pm
MYGN
2.6%
BEAT
5/7/2024
04:05 pm
MYGN
21.1%
BEAT
2/27/2024
04:05 pm
MYGN
-8.0%
BEAT
11/18
08:24 am
Maintains
Equal-Weight
Equal-Weight
Morgan Stanley
Medium
-4.9%
11/18
08:24 am
Maintains
Equal-Weight
Equal-Weight
Morgan Stanley
Medium
-4.9%
9/19
07:58 am
Initiates
Equal Weight
Morgan Stanley
Low
-0.6%
9/19
07:58 am
Initiates
Equal Weight
Morgan Stanley
Low
-0.6%
9/19
06:41 am
Initiates
Equal-Weight
Morgan Stanley
Low
-0.6%
11/14
04:17 pm
mygn
Low
Form SC 13G/A MYRIAD GENETICS INC Filed by: GLENVIEW CAPITAL MANAGEMENT, LLC
11/8
08:19 am
mygn
High
Form 10-Q MYRIAD GENETICS INC For: Sep 30
11/7
04:14 pm
mygn
Medium
Form 8-K MYRIAD GENETICS INC For: Nov 07
10/11
05:24 pm
mygn
Medium
Form 4 MYRIAD GENETICS INC For: Oct 11 Filed by: DIAZ PAUL J
10/11
10:35 am
mygn
Low
Form 144 MYRIAD GENETICS INC Filed by: DIAZ PAUL J
Show more
Top News Gainers
8/1 Form 8-K MYRIAD GENETICS INC For: Aug 01 55.0%
4/6 Myriad Receives Reimbursement for the BRACAnalysis® Diagnostic System in Japan for Patients with Breast or Ovarian Cancer Associated with HBOC 25.2%
3/23 Myriad Announces Board of Directors Leadership Transition 12.5%
11/6 GeneSight® Psychotropic Test Improved Clinical Outcomes for People with Depression Who Were Taking Medications with Gene-Drug Interactions 11.5%
8/16 Myriad Genetics, Inc. (NASDAQ: MYGN) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.6%
12/4 Myriad’s Prequel™ Prenatal Screen has Superior Sensitivity in Women with High BMI Undergoing Non-Invasive Prenatal Screening 7.9%
3/25 Myriad Genetics, Inc. (NASDAQ: MYGN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 7.1%
8/2 Myriad Genetics, Inc. (NASDAQ: MYGN) was upgraded by analysts at Bank of America Corp from an "underperform" rating to a "neutral" rating. 6.8%
11/23 DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. and Encourages Investors to Contact the Firm 6.4%
4/28 Myriad to Announce Fiscal Third-Quarter 2020 Financial Results on May 5, 2020 6.2%
Top News Decliners
8/13 Q4/2019 6/30/2019 EPS 0.410 ZacksConsensus 0.400 ActVsEst 0.010 - Beat -42.8%
11/4 Q1/2020 9/30/2019 EPS 0.080 ZacksConsensus 0.260 ActVsEst (0.180) - Miss -40.1%
2/6 Q2/2020 12/31/2019 EPS 0.230 ZacksConsensus 0.220 ActVsEst 0.010 - Beat -28.2%
5/7 Form 8-K MYRIAD GENETICS INC For: May 07 -21.4%
8/14 Myriad Genetics, Inc. (NASDAQ: MYGN) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. -9.9%
8/22 Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention -8.1%
6/14 Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at Barclays PLC from $18.00 to $20.00. They now have an "underweight" rating on the stock. -7.7%
2/7 Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at Piper Sandler from to . -6.3%
3/17 Myriad Genetics, Inc. (NASDAQ: MYGN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.0%
8/7 Myriad Will Seek FDA Approval of BRACAnalysis CDx® As a Companion Diagnostic for Lynparza® (olaparib) In Men with Metastatic Castrate-Resistant Prostate Cancer -4.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3